Noven Pharmaceuticals, Inc.
Records under this name other than the patents Noven Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 32 patents it holds.
Back to Noven Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,658,663 | Method of Treating Thermoregulatory Disfunction with Paroxetine Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,859,576 | Method of Treating Thermoregulatory Dysfunction with Paroxetine Formerly held Term ended Term ended Aug 4, 2026 · Medium confidence | Term ended | Term ended Aug 4, 2026 | Medium confidence |
| US 8,946,251 | Method of Treating Thermoregulatory Dysfunction with Paroxetine Formerly held Term ended Term ended Aug 4, 2026 · Medium confidence | Term ended | Term ended Aug 4, 2026 | Medium confidence |
| US 9,393,237 | Method of Treating Thermoregulatory Dysfunction with Paroxetine Formerly held Term ended Term ended Aug 4, 2026 · Medium confidence | Term ended | Term ended Aug 4, 2026 | Medium confidence |
| US 8,715,723 | Compositions and methods for delivery of amino-functional drugs Lapsed on the fee record Ended May 6, 2026 · USPTO record | Lapsed on the fee record | Ended May 6, 2026 | USPTO record |
| US 8,703,175 | Compositions and methods for controlling drug loss and delivery in transdermal drug delivery systems Lapsed on the fee record Ended Apr 22, 2026 · USPTO record | Lapsed on the fee record | Ended Apr 22, 2026 | USPTO record |
| US 8,153,151 | Composition and method for controlling drug delivery from silicone adhesive blends Term ended Term ended Feb 16, 2026 · USPTO record | Term ended | Term ended Feb 16, 2026 | USPTO record |
| US 8,591,941 | Transdermal drug delivery device including an occlusive backing Term ended Term ended Oct 7, 2025 · USPTO record | Term ended | Term ended Oct 7, 2025 | USPTO record |
| US 8,632,802 | Device for transdermal administration of drugs including acrylic polymers Term ended Term ended Oct 7, 2025 · USPTO record | Term ended | Term ended Oct 7, 2025 | USPTO record |
| US 8,865,207 | Compositions and methods for delivering active agents in transdermal drug delivery systems Term ended Ended no later than Oct 7, 2025 · USPTO record | Term ended | Ended no later than Oct 7, 2025 | USPTO record |